The global Gene Therapy On Cardiovascular Disease market was valued at US$ 13 million in 2023 and is anticipated to reach US$ 8593.6 million by 2030, witnessing a CAGR of 91.0% during the forecast period 2024-2030.

Gene Therapy On Cardiovascular Disease Market

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential treatment option for acquired and inherited cardiovascular diseases that remain with unmet clinical needs.

Global key players of Gene Therapy On Cardiovascular Disease include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals and Amgen, etc. Top three players occupy for a share about 76%. In terms of product, Non-Viral Gene Therapy is the largest segment, with a share over 100%. In terms of application, Vascular Disease is the largest market, with a share over 100%.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy On Cardiovascular Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy On Cardiovascular Disease.

Report Scope

The Gene Therapy On Cardiovascular Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy On Cardiovascular Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy On Cardiovascular Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapy On Cardiovascular Disease Market Report

Report Metric	Details
Report Name	Gene Therapy On Cardiovascular Disease Market
Accounted market size in 2023	US$ 13 million
Forecasted market size in 2030	US$ 8593.6 million
CAGR	91.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Viral Gene Therapy Non-Viral Gene Therapy
Segment by Application	Heart Disease Vascular Disease
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy On Cardiovascular Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene Therapy On Cardiovascular Disease Market growing?

Ans: The Gene Therapy On Cardiovascular Disease Market witnessing a CAGR of 91.0% during the forecast period 2024-2030.

What is the Gene Therapy On Cardiovascular Disease Market size in 2030?

Ans: The Gene Therapy On Cardiovascular Disease Market size in 2030 will be US$ 8593.6 million.

What is the market share of major companies in Gene Therapy On Cardiovascular Disease Market?

Ans: Top three players occupy for a share about 76%.

What is the Gene Therapy On Cardiovascular Disease Market share by application?

Ans: In terms of application, Vascular Disease is the largest market, with a share over 100%.

Who are the main players in the Gene Therapy On Cardiovascular Disease Market report?

Ans: The main players in the Gene Therapy On Cardiovascular Disease Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Gene Therapy On Cardiovascular Disease Market report?

Ans: The Applications covered in the Gene Therapy On Cardiovascular Disease Market report are Heart Disease, Vascular Disease

What are the Type segmentation covered in the Gene Therapy On Cardiovascular Disease Market report?

Ans: The Types covered in the Gene Therapy On Cardiovascular Disease Market report are Viral Gene Therapy, Non-Viral Gene Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Viral Gene Therapy

1.2.3 Non-Viral Gene Therapy

1.3 Market by Application

1.3.1 Global Gene Therapy On Cardiovascular Disease Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Heart Disease

1.3.3 Vascular Disease

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy On Cardiovascular Disease Market Perspective (2019-2030)

2.2 Gene Therapy On Cardiovascular Disease Growth Trends by Region

2.2.1 Global Gene Therapy On Cardiovascular Disease Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Gene Therapy On Cardiovascular Disease Historic Market Size by Region (2019-2024)

2.2.3 Gene Therapy On Cardiovascular Disease Forecasted Market Size by Region (2025-2030)

2.3 Gene Therapy On Cardiovascular Disease Market Dynamics

2.3.1 Gene Therapy On Cardiovascular Disease Industry Trends

2.3.2 Gene Therapy On Cardiovascular Disease Market Drivers

2.3.3 Gene Therapy On Cardiovascular Disease Market Challenges

2.3.4 Gene Therapy On Cardiovascular Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy On Cardiovascular Disease Players by Revenue

3.1.1 Global Top Gene Therapy On Cardiovascular Disease Players by Revenue (2019-2024)

3.1.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Players (2019-2024)

3.2 Global Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Therapy On Cardiovascular Disease Revenue

3.4 Global Gene Therapy On Cardiovascular Disease Market Concentration Ratio

3.4.1 Global Gene Therapy On Cardiovascular Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy On Cardiovascular Disease Revenue in 2023

3.5 Gene Therapy On Cardiovascular Disease Key Players Head office and Area Served

3.6 Key Players Gene Therapy On Cardiovascular Disease Product Solution and Service

3.7 Date of Enter into Gene Therapy On Cardiovascular Disease Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy On Cardiovascular Disease Breakdown Data by Type

4.1 Global Gene Therapy On Cardiovascular Disease Historic Market Size by Type (2019-2024)

4.2 Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Type (2025-2030)

5 Gene Therapy On Cardiovascular Disease Breakdown Data by Application

5.1 Global Gene Therapy On Cardiovascular Disease Historic Market Size by Application (2019-2024)

5.2 Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Gene Therapy On Cardiovascular Disease Market Size (2019-2030)

6.2 North America Gene Therapy On Cardiovascular Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024)

6.4 North America Gene Therapy On Cardiovascular Disease Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapy On Cardiovascular Disease Market Size (2019-2030)

7.2 Europe Gene Therapy On Cardiovascular Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024)

7.4 Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size (2019-2030)

8.2 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024)

8.4 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapy On Cardiovascular Disease Market Size (2019-2030)

9.2 Latin America Gene Therapy On Cardiovascular Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024)

9.4 Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size (2019-2030)

10.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024)

10.4 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Detail

11.1.2 Biogen Business Overview

11.1.3 Biogen Gene Therapy On Cardiovascular Disease Introduction

11.1.4 Biogen Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.1.5 Biogen Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Gene Therapy On Cardiovascular Disease Introduction

11.2.4 Novartis Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Detail

11.3.2 Gilead Sciences Business Overview

11.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Introduction

11.3.4 Gilead Sciences Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.3.5 Gilead Sciences Recent Development

11.4 Sarepta Therapeutics

11.4.1 Sarepta Therapeutics Company Detail

11.4.2 Sarepta Therapeutics Business Overview

11.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Introduction

11.4.4 Sarepta Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.4.5 Sarepta Therapeutics Recent Development

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Detail

11.5.2 Alnylam Pharmaceuticals Business Overview

11.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Introduction

11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.5.5 Alnylam Pharmaceuticals Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Gene Therapy On Cardiovascular Disease Introduction

11.6.4 Amgen Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.6.5 Amgen Recent Development

11.7 Spark Therapeutics

11.7.1 Spark Therapeutics Company Detail

11.7.2 Spark Therapeutics Business Overview

11.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Introduction

11.7.4 Spark Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.7.5 Spark Therapeutics Recent Development

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Detail

11.8.2 Akcea Therapeutics Business Overview

11.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Introduction

11.8.4 Akcea Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.8.5 Akcea Therapeutics Recent Development

11.9 bluebird bio

11.9.1 bluebird bio Company Detail

11.9.2 bluebird bio Business Overview

11.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Introduction

11.9.4 bluebird bio Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.9.5 bluebird bio Recent Development

11.10 Sunway Biotech

11.10.1 Sunway Biotech Company Detail

11.10.2 Sunway Biotech Business Overview

11.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Introduction

11.10.4 Sunway Biotech Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.10.5 Sunway Biotech Recent Development

11.11 SIBIONO

11.11.1 SIBIONO Company Detail

11.11.2 SIBIONO Business Overview

11.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Introduction

11.11.4 SIBIONO Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.11.5 SIBIONO Recent Development

11.12 AnGes

11.12.1 AnGes Company Detail

11.12.2 AnGes Business Overview

11.12.3 AnGes Gene Therapy On Cardiovascular Disease Introduction

11.12.4 AnGes Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.12.5 AnGes Recent Development

11.13 Orchard Therapeutics

11.13.1 Orchard Therapeutics Company Detail

11.13.2 Orchard Therapeutics Business Overview

11.13.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Introduction

11.13.4 Orchard Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.13.5 Orchard Therapeutics Recent Development

11.14 Human Stem Cells Institute

11.14.1 Human Stem Cells Institute Company Detail

11.14.2 Human Stem Cells Institute Business Overview

11.14.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Introduction

11.14.4 Human Stem Cells Institute Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024)

11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Human Stem Cells Institute

Biogen

List of Tables

Table 1. Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Viral Gene Therapy

Table 3. Key Players of Non-Viral Gene Therapy

Table 4. Global Gene Therapy On Cardiovascular Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Gene Therapy On Cardiovascular Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Gene Therapy On Cardiovascular Disease Market Share by Region (2019-2024)

Table 8. Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Gene Therapy On Cardiovascular Disease Market Share by Region (2025-2030)

Table 10. Gene Therapy On Cardiovascular Disease Market Trends

Table 11. Gene Therapy On Cardiovascular Disease Market Drivers

Table 12. Gene Therapy On Cardiovascular Disease Market Challenges

Table 13. Gene Therapy On Cardiovascular Disease Market Restraints

Table 14. Global Gene Therapy On Cardiovascular Disease Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Gene Therapy On Cardiovascular Disease Market Share by Players (2019-2024)

Table 16. Global Top Gene Therapy On Cardiovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy On Cardiovascular Disease as of 2023)

Table 17. Ranking of Global Top Gene Therapy On Cardiovascular Disease Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Gene Therapy On Cardiovascular Disease Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Gene Therapy On Cardiovascular Disease Product Solution and Service

Table 21. Date of Enter into Gene Therapy On Cardiovascular Disease Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene Therapy On Cardiovascular Disease Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Type (2019-2024)

Table 25. Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Type (2025-2030)

Table 27. Global Gene Therapy On Cardiovascular Disease Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Application (2019-2024)

Table 29. Global Gene Therapy On Cardiovascular Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Application (2025-2030)

Table 31. North America Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Gene Therapy On Cardiovascular Disease Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Gene Therapy On Cardiovascular Disease Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country (2025-2030) & (US$ Million)

Table 46. Biogen Company Detail

Table 47. Biogen Business Overview

Table 48. Biogen Gene Therapy On Cardiovascular Disease Product

Table 49. Biogen Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 50. Biogen Recent Development

Table 51. Novartis Company Detail

Table 52. Novartis Business Overview

Table 53. Novartis Gene Therapy On Cardiovascular Disease Product

Table 54. Novartis Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Gilead Sciences Company Detail

Table 57. Gilead Sciences Business Overview

Table 58. Gilead Sciences Gene Therapy On Cardiovascular Disease Product

Table 59. Gilead Sciences Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 60. Gilead Sciences Recent Development

Table 61. Sarepta Therapeutics Company Detail

Table 62. Sarepta Therapeutics Business Overview

Table 63. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product

Table 64. Sarepta Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 65. Sarepta Therapeutics Recent Development

Table 66. Alnylam Pharmaceuticals Company Detail

Table 67. Alnylam Pharmaceuticals Business Overview

Table 68. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product

Table 69. Alnylam Pharmaceuticals Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 70. Alnylam Pharmaceuticals Recent Development

Table 71. Amgen Company Detail

Table 72. Amgen Business Overview

Table 73. Amgen Gene Therapy On Cardiovascular Disease Product

Table 74. Amgen Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 75. Amgen Recent Development

Table 76. Spark Therapeutics Company Detail

Table 77. Spark Therapeutics Business Overview

Table 78. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product

Table 79. Spark Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 80. Spark Therapeutics Recent Development

Table 81. Akcea Therapeutics Company Detail

Table 82. Akcea Therapeutics Business Overview

Table 83. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product

Table 84. Akcea Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 85. Akcea Therapeutics Recent Development

Table 86. bluebird bio Company Detail

Table 87. bluebird bio Business Overview

Table 88. bluebird bio Gene Therapy On Cardiovascular Disease Product

Table 89. bluebird bio Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 90. bluebird bio Recent Development

Table 91. Sunway Biotech Company Detail

Table 92. Sunway Biotech Business Overview

Table 93. Sunway Biotech Gene Therapy On Cardiovascular Disease Product

Table 94. Sunway Biotech Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 95. Sunway Biotech Recent Development

Table 96. SIBIONO Company Detail

Table 97. SIBIONO Business Overview

Table 98. SIBIONO Gene Therapy On Cardiovascular Disease Product

Table 99. SIBIONO Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 100. SIBIONO Recent Development

Table 101. AnGes Company Detail

Table 102. AnGes Business Overview

Table 103. AnGes Gene Therapy On Cardiovascular Disease Product

Table 104. AnGes Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 105. AnGes Recent Development

Table 106. Orchard Therapeutics Company Detail

Table 107. Orchard Therapeutics Business Overview

Table 108. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product

Table 109. Orchard Therapeutics Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 110. Orchard Therapeutics Recent Development

Table 111. Human Stem Cells Institute Company Detail

Table 112. Human Stem Cells Institute Business Overview

Table 113. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product

Table 114. Human Stem Cells Institute Revenue in Gene Therapy On Cardiovascular Disease Business (2019-2024) & (US$ Million)

Table 115. Human Stem Cells Institute Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene Therapy On Cardiovascular Disease Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Gene Therapy On Cardiovascular Disease Market Share by Type: 2023 VS 2030

Figure 3. Viral Gene Therapy Features

Figure 4. Non-Viral Gene Therapy Features

Figure 5. Global Gene Therapy On Cardiovascular Disease Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Gene Therapy On Cardiovascular Disease Market Share by Application: 2023 VS 2030

Figure 7. Heart Disease Case Studies

Figure 8. Vascular Disease Case Studies

Figure 9. Gene Therapy On Cardiovascular Disease Report Years Considered

Figure 10. Global Gene Therapy On Cardiovascular Disease Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Gene Therapy On Cardiovascular Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Gene Therapy On Cardiovascular Disease Market Share by Region: 2023 VS 2030

Figure 13. Global Gene Therapy On Cardiovascular Disease Market Share by Players in 2023

Figure 14. Global Top Gene Therapy On Cardiovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy On Cardiovascular Disease as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy On Cardiovascular Disease Revenue in 2023

Figure 16. North America Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Gene Therapy On Cardiovascular Disease Market Share by Country (2019-2030)

Figure 18. United States Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Gene Therapy On Cardiovascular Disease Market Share by Country (2019-2030)

Figure 22. Germany Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Gene Therapy On Cardiovascular Disease Market Share by Region (2019-2030)

Figure 30. China Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Gene Therapy On Cardiovascular Disease Market Share by Country (2019-2030)

Figure 38. Mexico Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Share by Country (2019-2030)

Figure 42. Turkey Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Gene Therapy On Cardiovascular Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Biogen Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 45. Novartis Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 46. Gilead Sciences Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 47. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 48. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 49. Amgen Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 50. Spark Therapeutics Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 51. Akcea Therapeutics Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 52. bluebird bio Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 53. Sunway Biotech Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 54. SIBIONO Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 55. AnGes Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 56. Orchard Therapeutics Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 57. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy On Cardiovascular Disease Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Respiratory Infection Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39D3651

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Internal Neuromodulation Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24F2529

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions